The
patient blood management market industry is projected to grow from USD 8.04
Billion in 2023 to USD 14.022 billion by 2032, exhibiting a compound annual
growth rate (CAGR) of 7.20% during the forecast period (2023 - 2032).
The
Patient Blood Management (PBM) market continues its upward trajectory, fueled by
rising awareness of blood conservation strategies and advancements in
healthcare technologies. With a focus on minimizing blood transfusions, PBM
emphasizes preoperative optimization, intraoperative techniques, and
postoperative care to enhance patient outcomes. Factors such as increasing
surgical procedures, aging populations, and a growing prevalence of chronic
diseases contribute to market expansion. Innovations in blood testing,
transfusion alternatives, and comprehensive patient care protocols drive market
growth. Moreover, stringent regulatory standards and healthcare cost
containment efforts influence market dynamics. As stakeholders prioritize
patient safety and cost-effectiveness, the PBM market anticipates sustained
growth globally.
Patient
Blood Management (PBM) is a healthcare approach focused on optimizing patient
outcomes by effectively and safely managing the patient's blood. The Patient
Blood Management Market has witnessed significant growth, driven by the
increasing awareness of the importance of blood conservation and the rising
demand for efficient blood utilization strategies.
Blood
utilization plays a pivotal role in PBM, emphasizing the judicious use of blood
products to minimize unnecessary transfusions. Hospitals and healthcare
facilities are adopting comprehensive PBM programs that prioritize patient
safety and reduce the reliance on blood transfusions. This approach not only
enhances patient outcomes but also addresses the challenges associated with
blood shortages.
Blood products, including red blood cells, plasma, and
platelets, are crucial components of PBM. The market is witnessing advancements
in blood product technologies, ensuring better storage, transportation, and
utilization. This not only improves the overall efficiency of blood management
but also contributes to cost savings in healthcare settings.
As
healthcare providers recognize the significance of PBM in enhancing patient
care, the Patient Blood Management Market is poised for continuous growth. The
integration of innovative solutions for blood utilization and the development
of safer and more efficient blood products are expected to drive the market
forward, shaping the future of healthcare with a focus on patient-centric and
sustainable blood management practices.
Market
Segmentation
The
MRFR report offers an inclusive segmental analysis of the global patient blood
management market report based on end user, component, and product.
By
product, the global patient blood management market is segmented into software,
reagents and kits, and instrument accessories. Of these, the instruments
segment will lead the market over the forecast period.
By
component, the market is segmented into plasma and whole blood. Of these, the
whole blood segment will dominate the market over the forecast period for the
huge preference for blood transfusion.
By
end user segment, the market is segmented into pathology labs, diagnostic
clinics, hospitals, and blood banks. Of these, the blood bank segment will have
a major share over the forecast period as these are primary locations patients
get blood-related products.
Regional
Analysis
Based
on the region, the global patient blood management market report covers the
recent trends and growth opportunities across the Americas, Europe, the Asia
Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas
will spearhead the market over the forecast period. The growing prevalence of
cancer, the increasing number of surgical procedures, the presence of a
well-established healthcare sector, and the presence of several hospitals in
the US are adding to the growth of the market in the region.
The
market in Europe is predicted to have favourable growth over the forecast
period. The presence of well-developed healthcare systems, rising cases of road
traffic accidents, and a rising number of blood donations are adding to the
growth of the market over the forecast period.
The
market in the APAC region is predicted to grow at a fast pace over the forecast
period. The rapidly growing healthcare sector and huge population are adding to
the growth of the market in the region.
The
market in the MEA is predicted to have the smallest share over the forecast
period for the limited healthcare facility development.
Key
Players
The
patient blood management companies include Immucor, Inc., Grifols, S.A,
Terumo Corporation, Hitachi, Ltd., Danaher Corporation, Abbott Laboratories, B.
Braun Melsungen AG, Fresenius Se & Co. KGaA, Bio-Rad Laboratories, Inc.,
and Biomérieux SA. Industry players have encompassed several strategies to
create a niche in the market and also cater to the burgeoning needs of
customers. These comprise yet is not limited to geographic expansions, joint
ventures and collaborations, partnerships, strategic alliances, contracts,
mergers and acquisitions, new product launches and development, extensive
research and development activities, and more.
Related Reports:
U.S. Dietary supplements
Type 2 Diabetes Mellitus
Treatment
Pseudotumor Cerebri
Healthcare Supply Chain
Management
Body Sensors
For More Information, Please
Visit @ Market
Research Future
Comments
Post a Comment